#186 Addressing Spike Protein, Genomic Integration and Cancer Risks Dr. John A. Catanzaro

Dr. John A. Catanzaro discusses the implications of spike proteins associated with mRNA vaccines, their impact on mitochondrial function, and the potential risks of genomic integration leading to cancer. He emphasizes the need for molecular surveillance and precision medicine to address the health issues arising from these proteins. The discussion also touches on the importance of natural healing modalities and the hope for recovery through a better understanding of the underlying health challenges.

Dr. Catanzaro is a pioneering leader in precision molecular medicine, specializing in personalized peptide engineering, OMICS-driven bioinformatics therapeutics, and signal-based molecular interventions. He earned his Doctorate of Naturopathic Medicine (NMD) from Bastyr University in 1995 and a Doctorate of Theology in Science and Medical Ethics (PhD) from Bethany Divinity Seminary in 2012.

With over two decades of expertise in precision and integrative medicine, Dr. Catanzaro has spearheaded advancements in high-definition molecular surveillance and immunomolecular augmentation, developing groundbreaking personalized peptide solutions for complex disease states. He is the co-inventor of an augmented hybrid intelligence (aHI) system, an advanced platform that seamlessly integrates human intelligence, knowledge-based applications, and AI. This innovation powers the Precision-Based Immunomolecular Augmentation (PBIMA) platform—a revolutionary approach that optimizes cellular function through patient-specific molecular data.

https://neo7bioscience.com/